GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma

Clinical trial NCT05650749 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05650749
Sponsor: Stephan Grupp MD PhD
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Neuroblastoma Relapsed Neuroblastoma High-risk Neuroblastoma Retinoblastoma Metastatic Retinoblastoma

Start date: 2023-05-23
Primary completion: 2028-01-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.